Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies

Global repositories of postmarketing safety reports improve understanding of real-life drug toxicities, often not observed in clinical trials. The aim of this scoping review was to map the evidence from spontaneous reporting systems studies (SRSs) of antiangiogenic drugs (AADs) in cancer patients an...

Full description

Bibliographic Details
Main Authors:	Valerio Ciccone, Marina Ziche, Andrea Spini, Sandra Donnini
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	Pharmaceuticals
Subjects:	angiogenesis adverse drug reaction VEGF disproportionality analysis postmarketing surveillance spontaneous reporting systems
Online Access:	https://www.mdpi.com/1424-8247/16/6/867

Similar Items

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
by: Paola Maria Cutroneo, et al.
Published: (2024-01-01)

Statistical methods for exploring spontaneous adverse event reporting databases for drug-host factor interactions
by: Zhiyuan Lu, et al.
Published: (2023-03-01)

Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital
by: Fabiana Rossi Varallo, et al.
Published: (2014-03-01)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021-08-01)

Development of instrument to report and assess causality of adverse events related to herbal medicines
by: Patrícia de Carvalho Mastroianni, et al.

Comparison of rates of nausea side effects for prescription medications from an online patient community versus medication labels: an exploratory analysis
by: David A. Blaser, et al.
Published: (2017-11-01)

Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis
by: Andrea Spini, et al.
Published: (2022-10-01)

Status and Safety Signals of Cephalosporins in Children: A Spontaneous Reporting Database Study
by: Yuanxuan Cai, et al.
Published: (2021-10-01)

Analysis of Adverse Reactions in Elderly Patients Based on Quantitative Methods of Signal Detection
by: K. E. Zalolochina, et al.
Published: (2021-10-01)

Underreporting and Triggering Factors for Reporting ADRs of Two Ophthalmic Drugs: A Comparison between Spontaneous Reports and Active Pharmacovigilance Databases
by: Homero Contreras-Salinas, et al.
Published: (2022-10-01)

Characteristics of Phase IV Clinical Trials in Oncology: An Analysis Using the ClinicalTrials.gov Registry Data
by: Brandon Michael Henry, et al.
Published: (2023-06-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
by: O. V. Shatalova, et al.
Published: (2015-09-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
by: O. V. Shatalova, et al.
Published: (2015-09-01)

From Monitoring Drug Safety to Monitoring Patient Safety: A Strategic Focus for the Activity of Pharmacists
by: Francisco Batel Marques
Published: (2017-10-01)

Characteristics of “Hard-to-Use” Press-Through-Package Sheets: An Analysis of Information Collected by Marketing Specialists of a Japanese Medical Wholesaler
by: Kabeya K, et al.
Published: (2020-07-01)

Safety and effectiveness of apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A regulatory postmarketing surveillance, the STANDARD study
by: Hiroshi Inoue, et al.
Published: (2019-06-01)

In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorthiazide, among Palestinian hypertensive patients
by: Zaid AN, et al.
Published: (2016-09-01)

Adverse drug reactions induced by cardiovascular drugs in outpatients
by: Gholami K, et al.
Published: (2008-03-01)

Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine
by: Hashem O. Alsaab, et al.
Published: (2021-02-01)

Materiovigilance: An Indian perspective
by: Bikash Ranjan Meher
Published: (2018-01-01)

Spontaneous Reporting of Adverse Drug Reactions in a Pediatric Population in a Tertiary Hospital
by: Laura López-Valverde, et al.
Published: (2021-11-01)

Adverse drug reactions of macrolide therapy: analysis of spontaneous reports according to the Pharmacovigilance system
by: Skryabina A.A., et al.
Published: (2023-03-01)

Drug-Related Deaths in a Tertiary Hospital: Characteristics of Spontaneously Reported Cases and Comparison to Cases Detected from a Retrospective Study
by: Ana Lucía Arellano, et al.
Published: (2021-09-01)

Drug therapeutic failures as a cause of admission to an intensive care unit at a university hospital
by: Jair Antonio Ruiz-Garzon, et al.
Published: (2019-01-01)

Study on the Classification, Causality, Preventability and Severity of Adverse Drug Reaction Using Spontaneous Reporting System in Hospitalized Patients
by: Siraj Sundaran, et al.
Published: (2018-09-01)

A Standardized Dataset of a Spontaneous Adverse Event Reporting System
by: Mohammad Ali Khaleel, et al.
Published: (2022-02-01)

Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system
by: Hongli Wang, et al.
Published: (2024-01-01)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
by: Dongxuan Li, et al.
Published: (2023-04-01)

Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study
by: Shigeomi Iimura, et al.
Published: (2023-09-01)

Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): One‐year safety and effectiveness analyses
by: Takeshi Yamashita, et al.
Published: (2020-06-01)

The readiness of the spontaneous reporting system for COVID-19 vaccines safety monitoring in Croatia
by: Kovačić Barbara, et al.
Published: (2023-06-01)

Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01)

Analysis of the decisions of foreign regulatory authorities
by: Relevant information
Published: (2019-06-01)

Drug Safety Monitoring—International Information
by: E. V. Shubnikova, et al.
Published: (2020-12-01)

Monitoring of Foreign Drug Safety Information
by: Editorial article
Published: (2019-12-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

Spontaneously Reported Adverse Drug Reactions and Their Description in Hospital Discharge Reports: A Retrospective Study
by: Cristina Aguilera, et al.
Published: (2021-07-01)

Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
by: Dongxuan Li, et al.
Published: (2023-12-01)

Evaluation of knowledge, attitude, and practice of adverse drug reactions reporting among doctors and nursing staff of a rural tertiary care teaching hospital of Maharashtra
by: Satish E Bahekar, et al.
Published: (2018-01-01)

Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS)
by: Victor Pera, et al.
Published: (2023-11-01)